Clinical Trial Update: Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating spectroscopic MRI-guided radiation therapy planning for glioblastoma and gliosarcoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma

Snippet

Sponsor: Emory University | Conditions: Glioblastoma, Gliosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2025-08-03